USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Pharma Clinical Trial Digitization—Companies to Action, 2019
Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market
11-Apr-2019
North America
Market Research
$1,500.00
Special Price $1,125.00 save 25 %
Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centric and efficient distributed settings. As the clinical trial industry transitions to biomarker-based, targeted therapeutics, it demands a pivotal shift in design focus: from one directed by researchers to one driven by the needs of patients and their caregivers. Frost & Sullivan observes that leading pharmaceutical companies, in particular, are aggressively moving toward the mixed approach of physical and remote clinical trial settings to improve patient engagement and justify the value of future personalized drugs. Furthermore, increasing demand for quality data and novel endpoints demands clinical trial data management solutions to shift from fragmented point solutions that sit in silos to integrated eClinical solutions that provide a single source of truth, optimizing the cost by eliminating duplicate data entry, reducing on-site verification and source data verification rate. This entails an evolving vendor ecosystem of modular cloud-based eClinical solutions with an intuitive user interface capable of integrating all possible study and eSource data to optimize clinical trial digital workflows and data management cost and time.
Research Scope
The research service analyzes the 3 big themes driving clinical trial digitization and the new vendor ecosystem. The study also highlights growth opportunities, case studies of notable market developments, key trends, and investment and collaboration opportunities. Furthermore, the study provides an analysis of major companies segregated by these top 3 themes, which include:
- Digital Continuity Across Clinical Trial IT Systems: Digital continuity provides the framework and transparency required throughout the drug’s lifecycle, from discovery to post approval. Leading clinical trial IT vendors provide propriety or third-party-hosted cloud-based eClinical platforms.
- Patient-centric Remote and Virtual Trial Design: The new pharma era breeds customer centricity, innovation, and engagement with patients, physicians, and all partners in the healthcare ecosystem.
- Direct-to-patient Home Services: Beyond the technological readiness, deployment of remote/virtual clinical trials will heavily rely on DTP clinical supplies and logistics services to meet patients and caregivers where they are.
Companies mentioned in the study are Oracle (ClinicalOne), Medidata Solutions, Science 37, THREAD Research, Evidation Health, ActiGraph, Veeva Systems, Antidote Technologies, Inc., ConsilX, 4G Clinical, CliniOps Inc, CRF, Koneska Health, Aparito, Clinerion, TrialBee, TriNetX Network, PatientsLikeMe, and Deep 6 AI.
Key Issues Addressed
- What are the growth opportunities in clinical trials digitization space? What is the impact of the external environment on this market?
- What are the unique companies that are introducing innovative digital solutions in the market?
- How can companies transform clinical trial operations to provide much-needed patient-centric trials and efficiencies?
- What are the action plans and what is the potential for growth for disruptive and innovative companies in the clinical trials digitization space?
- What is the convergence potential of emerging technologies across the clinical development value chain (such as mHealth, wearables, AI, IoT, and blockchain)?
- How does the future vendor ecosystem for clinical trials look?
Author: Kamaljit Behera
Key Findings
Strategic Imperatives for Key Industry Stakeholders
Top 5 Growth Opportunities
Scope and Segmentation
Key Questions this Study will Answer
Industry Convergence Driving Disruption and Innovation
Frost & Sullivan Companies to Action—Potential to Disrupt Healthcare Industry Paradigms
Technology Convergence Transforming Clinical Trial Models
Market Definition and Segmentation
Clinical Trial IT Market—Major Application Segments and Technologies
Digital Continuity
Challenges and Role of mHealth Solutions
Distributed Clinical Trials Ecosystem—Future Vision (2025)
Top 3 Trends and Vendor Strategies
C2A Targets Aligned with Top 3 Trends
Value Chain Analysis
Clinical Trial Digital Solutions—Analysis of Companies to Action
Clinical One by Oracle
Clinical One by Oracle (continued)
Medidata eClinical Solutions
Medidata eClinical Solutions (continued)
Science 37
Science 37 (continued)
THREAD Research
THREAD Research (continued)
Marken
Marken (continued)
ActiGraph
ActiGraph (continued)
Antidote Technologies, Inc
Antidote Technologies, Inc (continued)
CONSILX
CONSILX (continued)
Short Profiles of Clinical Trial Digital Solutions Companies
Short Profiles of Clinical Trial Digital Solutions Companies (continued)
Short Profiles of Clinical Trial Digital Solutions Companies (continued)
Entry of Non-traditional Participants
Key Conclusions
Legal Disclaimer
List of Abbreviations and Acronyms
Short Capability Matrix of Select Vendors Providing Clinical Trials Digital Solutions
Short Capability Matrix of Select Vendors Providing Clinical Trials Digital Solutions (continued)
Short Capability Matrix of Select Vendors Providing Clinical Trials Digital Solutions (continued)
Select Pharma and mHealth Vendor Collaboration Deals
Select Pharma and mHealth Vendor Collaboration Deals (continued)
Select Pharma and mHealth Vendor Collaboration Deals (continued)
Key Trends
Interested in Full Access? Connect With Us
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
The research service analyzes the 3 big themes driving clinical trial digitization and the new vendor ecosystem. The study also highlights growth opportunities, case studies of notable market developments, key trends, and investment and collaboration opportunities. Furthermore, the study provides an analysis of major companies segregated by these top 3 themes, which include:
- Digital Continuity Across Clinical Trial IT Systems
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Kamaljit Behera |
| Industries | Healthcare |
| WIP Number | 9AB9-00-A6-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9562-B1,9571-B1,9573-B1,99C1-B1,99C6-B1,9837-B1,9568-B1,9611-B1,9627-B1 |